Medpace Holdings, Inc. MEDP Direct Costs — Segment Reporting, Other Segment Item, Amount

Similar metrics at other companies

IQVResearch And Development Solutions — Cost Of Services Excluding Depreciation Depletion And Amortization

$971M+5.4%

GMEDReportable Segment — Other Research and Development Expense

$9.17M+20.2%

IQVContract Sales And Medical Solutions — Cost Of Services Excluding Depreciation Depletion And Amortization

$172M+0.6%

IQVResearch & Development Solutions — Cost of revenues, exclusive of depreciation and amortization

$1.68B+8.0%

BRTotal Reportable Segments — Other direct expenses

$1.32B+8.2%

STEProduct — Cost of Product and Service Sold

$456.8M+5.4%

Questions, answered.

What is Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount?

Medpace Holdings, Inc. (MEDP) reported direct costs — segment reporting, other segment item, amount of $33.67M in Q1 2026.

How has Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount changed year-over-year?

Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount decreased by 0.6% year-over-year, from $33.89M to $33.67M.

What is the long-term trend for Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount?

Over 3 years (2022 to 2025), Medpace Holdings, Inc.'s direct costs — segment reporting, other segment item, amount has grown at a 4.8% compound annual growth rate (CAGR), from $124.38M to $143.34M.

What does direct costs — segment reporting, other segment item, amount mean?

The portion of direct service costs that are not related to employee compensation.

How do you interpret direct costs — segment reporting, other segment item, amount?

An increase may reflect higher investment in technology or third-party services, whereas a decrease could indicate cost-saving initiatives or reduced reliance on external vendors.

How does direct costs — segment reporting, other segment item, amount compare across companies?

Comparable to other direct operating expenses or non-labor cost of services in the CRO industry.